ccfDNA In the Lab: Optimizing Purification for Sequencing


ccfDNA Webinar Series: The Basics and Beyond
Part 3 - ccfDNA In the Lab: Optimizing Purification for Sequencing

Circulating Cell-free DNA can be used to monitor tumor burden and monitor disease progress. In this webinar, Dr. Gulley discusses variables important to isolating high-quality ccfDNA from plasma samples including anticoagulant, plasma volume and storage length and conditions.

Have you seen the first 2 parts of the series?



Margaret Gulley, MD
Professor and Director of Molecular Pathology
University of North Carolina-Chapel Hill

Margaret L. Gulley MD is professor and Director of Molecular Pathology in the Department of Pathology and Laboratory Medicine at University of North Carolina at Chapel Hill, USA. She provides laboratory services to patients with cancer, heritable disease, infectious disease, or transplant. Dr. Gulley’s research on virus-related malignancy seeks to validate novel molecular assays that add value for disease classification and monitoring. Work with professional societies aims to promote high quality molecular services in clinical laboratories.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up